Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3635334012 | Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3636381018 | Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent (disorder) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3636382013 | Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
7634651000241119 | LMA (leucémie myéloïde aigüe) liée à un traitement due à l'administration d'un agent chimiothérapeutique | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
7634661000241116 | LMA (leucémie myéloïde aigüe) liée à un traitement due à l'administration d'un agent antitumoral | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
7634671000241112 | leucémie myéloïde aigüe liée à un traitement due à l'administration d'un agent antinéoplasique | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Due to | Administration of antineoplastic agent | true | Inferred relationship | Some | 1 | |
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | trouble causé par un médicament | false | Inferred relationship | Some | ||
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Complication of procedure | false | Inferred relationship | Some | ||
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | séquelle | false | Inferred relationship | Some | ||
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Complication of chemotherapy (disorder) | true | Inferred relationship | Some | ||
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) | false | Inferred relationship | Some | ||
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | After | Administration of antineoplastic agent | true | Inferred relationship | Some | 2 | |
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Associated morphology | Therapy-related acute myeloid leukemia and myelodysplastic syndrome | false | Inferred relationship | Some | 3 | |
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Causative agent (attribute) | Antineoplastic agent (substance) | true | Inferred relationship | Some | 3 | |
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Finding site | Bone marrow structure | true | Inferred relationship | Some | 3 | |
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Disorder following clinical procedure | false | Inferred relationship | Some | ||
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Complication of introduction procedure | true | Inferred relationship | Some | ||
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Drug-induced lesion | true | Inferred relationship | Some | ||
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Hematologic complication of procedure | true | Inferred relationship | Some | ||
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Neoplastic complication of procedure | true | Inferred relationship | Some | ||
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Therapy-related myelodysplastic syndrome (disorder) | true | Inferred relationship | Some | ||
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Associated morphology | Myeloid neoplasm post cytotoxic therapy (morphologic abnormality) | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbour unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain). | Is a | True | Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Inferred relationship | Some |
This concept is not in any reference sets